LYTIR

Insider · SEC Form 4 · Chief Scientific Officer

Kristian Reich

Filed with the SEC as Reich Kristian; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: sold $5.1M of MLTX. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $5.1M in total.Jun: Insider sales $2.9MJul: Insider sales $2.3MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $5.1M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. MLTXSold: MoonLake Immunotherapeutics Jul 27, 2026 1,100 shares filed Jul 29, 2026 2,711,198 shares held indirectly after, as filed 10b5-1 plan filing $22K
  2. MLTXSold: MoonLake Immunotherapeutics Jul 22, 2026 2,448 shares filed Jul 23, 2026 2,712,298 shares held indirectly after, as filed 10b5-1 plan filing $49K
  3. MLTXSold: MoonLake Immunotherapeutics Jul 21, 2026 50,000 shares filed Jul 23, 2026 2,714,746 shares held indirectly after, as filed 10b5-1 plan filing $1.0M
  4. MLTXSold: MoonLake Immunotherapeutics Jul 20, 2026 43,700 shares filed Jul 21, 2026 2,764,746 shares held indirectly after, as filed 10b5-1 plan filing $878K
  5. MLTXSold: MoonLake Immunotherapeutics Jul 15, 2026 16,105 shares filed Jul 20, 2026 2,808,446 shares held indirectly after, as filed 10b5-1 plan filing $322K
  6. MLTXSold: MoonLake Immunotherapeutics Jun 17, 2026 50,000 shares filed Jun 17, 2026 2,824,551 shares held indirectly after, as filed 10b5-1 plan filing $972K
  7. MLTXSold: MoonLake Immunotherapeutics Jun 16, 2026 50,000 shares filed Jun 17, 2026 2,874,551 shares held indirectly after, as filed 10b5-1 plan filing $935K
  8. MLTXSold: MoonLake Immunotherapeutics Jun 15, 2026 50,000 shares filed Jun 17, 2026 2,924,551 shares held indirectly after, as filed 10b5-1 plan filing $944K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.